Stock News & Analysis

Wondering what will happen when Anthropic goes public? SpaceX could have some answers.

Costco has a meaningfully better inventory turnover ratio.

Oracle is experiencing the growing pains that come with rapid development.

Sales growth is collapsing and could turn negative relatively soon.

The company has a history of developing treatments that have achieved widespread adoption.

This stock is worth loading up on whenever it's on the cheap side.

Illumina's AI strategy is reshaping the investment case. See how sequencing, biological data, and drug-discovery partnerships could change what drives the company next.

Past buybacks at Apple and at the chipmaker itself usually came before market-beating years. But was the buyback the reason?

The S&P 500 Shiller CAPE Ratio is over 40x, the highest level since the dot-com bubble.

An analyst at a top U.S. bank reiterated his positive outlook on the company.

A buyer from late 2011 now gets around 12% a year on what they paid. Can a buyer at today's price expect the same?

It's apparently deep in discussions to combine with a larger peer.

It was the subject of a recommendation upgrade from an analyst.

Airbnb finally looks ready for a bull run.

Bristol Myers Squibb trades at a fraction of Eli Lilly's valuation while generating substantial free cash flow, but concentration risk and explosive growth tell very different stories.

This potent exchange-traded fund has significantly outperformed the S&P 500 index.

Sandisk stock has room to run higher even after delivering a multibagger performance in 2026.

The storied industrials company just signed a multi-billion-dollar deal with a famous telecom.

An analyst has a new take on this energy stock, and investors aren't impressed.

Karman's director purchased shares at $37.32 each despite a -43% one-year return, bringing his direct stake to 3.5 million shares.